Prevalence and Determinants of Hypertension Awareness, Treatment, and Control in Botswana: A Nationally Representative Population-Based Survey.


Journal

International journal of hypertension
ISSN: 2090-0384
Titre abrégé: Int J Hypertens
Pays: United States
ID NLM: 101538881

Informations de publication

Date de publication:
2020
Historique:
received: 17 01 2020
revised: 29 04 2020
accepted: 01 05 2020
entrez: 19 6 2020
pubmed: 19 6 2020
medline: 19 6 2020
Statut: epublish

Résumé

Hypertension is a leading risk factor for cardiovascular mortality and an emerging public health concern in sub-Saharan Africa. Few studies have examined performance on the management of hypertension in this region, where the context may be distinct from other developing regions. We aimed to determine the prevalence and correlates of hypertension, awareness, treatment, and control among adults in Botswana, a middle-income African country undergoing rapid demographic transition and with high HIV burden. In this 2014 cross-sectional survey of adults aged 15-69 years, information on sociodemographic characteristics, lifestyle behavior, and medical history was collected through in-person interviews and physical measurements (body mass index and triplicate blood pressure (BP)). Hypertension was defined as self-report of use of antihypertensives in the previous two weeks and/or having elevated BP (≥140/90 mmHg). Multivariable logistic regression was employed to explore factors associated with hypertension, awareness (report of previous diagnosis), treatment (antihypertensives), and control (BP < 140/90). Our analysis ( We report the first nationally representative estimates of the hypertension care cascade performance in Botswana, which will support planning and future policy evaluations. Findings contribute to the relatively sparse evidence on this subject and may inform development of innovations that improve quality of hypertension management and adherence support in similar settings.

Identifiants

pubmed: 32550019
doi: 10.1155/2020/8082341
pmc: PMC7281842
doi:

Types de publication

Journal Article

Langues

eng

Pagination

8082341

Subventions

Organisme : Cancer Research UK
ID : 29186
Pays : United Kingdom
Organisme : NIAID NIH HHS
ID : K24 AI131928
Pays : United States
Organisme : NCI NIH HHS
ID : P20 CA210283
Pays : United States

Informations de copyright

Copyright © 2020 Neo M. Tapela et al.

Déclaration de conflit d'intérêts

The authors declare that they have no conflicts of interest.

Références

Hypertension. 2015 Feb;65(2):291-8
pubmed: 25385758
BMJ Glob Health. 2017 Aug 16;2(3):e000348
pubmed: 29082013
J Clin Hypertens (Greenwich). 2016 Nov;18(11):1146-1154
pubmed: 27481706
JAMA. 2003 May 21;289(19):2560-72
pubmed: 12748199
BMC Cardiovasc Disord. 2019 Jul 22;19(1):173
pubmed: 31331284
AIDS. 2018 Jul 1;32 Suppl 1:S43-S46
pubmed: 29952789
JAMA. 2013 Sep 4;310(9):959-68
pubmed: 24002282
PLoS One. 2016 Jan 19;11(1):e0146181
pubmed: 26784948
PLoS One. 2018 Mar 19;13(3):e0193494
pubmed: 29554106
PLoS One. 2013 Apr 17;8(4):e62236
pubmed: 23614041
BMC Public Health. 2018 Nov 7;18(Suppl 3):1219
pubmed: 30400858
J Am Soc Hypertens. 2018 Mar;12(3):239
pubmed: 29429956
J Hum Hypertens. 2019 Feb;33(2):157-166
pubmed: 30382179
Lancet. 2016 Mar 5;387(10022):957-967
pubmed: 26724178
JAMA. 2017 Sep 19;318(11):1016-1025
pubmed: 28975305
Lancet Glob Health. 2018 Jul;6(7):e736-e743
pubmed: 29778399
J Clin Hypertens (Greenwich). 2015 May;17(5):332-7
pubmed: 25703272
Blood Press Monit. 2010 Feb;15(1):49-54
pubmed: 20032779
BMJ Open. 2012 Aug 24;2(4):
pubmed: 22923629
N Engl J Med. 2001 Aug 16;345(7):479-86
pubmed: 11519501
Lancet. 2019 Aug 24;394(10199):652-662
pubmed: 31327566
Lancet. 2019 Oct 5;394(10205):1231-1242
pubmed: 31488369
J Clin Hypertens (Greenwich). 2016 Mar;18(3):232-9
pubmed: 26337797
Lancet. 2018 Sep 22;392(10152):1072-1088
pubmed: 30264707
BMC Public Health. 2019 May 6;19(1):511
pubmed: 31060545
Am J Public Health. 2015 Mar;105(3):431-7
pubmed: 25602898
Lancet. 2018 Nov 17;392(10160):2203-2212
pubmed: 30195398
Lancet. 2009 Sep 12;374(9693):934-47
pubmed: 19709736
Lancet Glob Health. 2018 Nov;6(11):e1196-e1252
pubmed: 30196093
Int J Epidemiol. 2014 Feb;43(1):116-28
pubmed: 24505082
Hypertension. 2009 Jul;54(1):77-83
pubmed: 19470872
Lancet. 2008 May 3;371(9623):1513-8
pubmed: 18456100
Circulation. 2016 May 24;133(21):2076-85
pubmed: 27217433
Bull World Health Organ. 2019 Feb 1;97(2):142-153
pubmed: 30728620
J Int AIDS Soc. 2019 Mar;22(3):e25213
pubmed: 30916897
AIDS Care. 2018 Jan;30(1):103-115
pubmed: 28679283

Auteurs

Neo M Tapela (NM)

Nuffield Department of Population Health, University of Oxford, Oxford, UK.
Botswana Harvard AIDS Institute Partnership, Gaborone, Botswana.

Lei Clifton (L)

Nuffield Department of Population Health, University of Oxford, Oxford, UK.

Gontse Tshisimogo (G)

National NCD Program, Ministry of Health and Wellness, Gaborone, Botswana.

Moagi Gaborone (M)

World Health Organization, Gaborone, Botswana.

Tebogo Madidimalo (T)

World Health Organization, Gaborone, Botswana.

Virginia Letsatsi (V)

National NCD Program, Ministry of Health and Wellness, Gaborone, Botswana.

Tiny Masupe (T)

University of Botswana, Gaborone, Botswana.

Mosepele Mosepele (M)

University of Botswana, Gaborone, Botswana.

Joseph Makhema (J)

Botswana Harvard AIDS Institute Partnership, Gaborone, Botswana.

Shahin Lockman (S)

Botswana Harvard AIDS Institute Partnership, Gaborone, Botswana.
Harvard T.H. Chan School of Public Health, Boston, MA, USA.

David J Hunter (DJ)

Nuffield Department of Population Health, University of Oxford, Oxford, UK.
Harvard T.H. Chan School of Public Health, Boston, MA, USA.

Classifications MeSH